GE HealthCare Technologies Inc. (GEHC) stock
Close on Nov 13, 2026Market cap $37.54BP/E 17.5Yield 0.17%
GE HealthCare Technologies Inc. grew revenue 6.9% to $21.64B over the twelve months to Sep 30, 2026. Operating income rose 5.4% to $2.89B, moving the operating margin from 13.5% to 13.3%. Free cash flow was $1.89B, up 34.9% from a year earlier. At the latest close the market valued the company at $37.54B, 17.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $37.54B
- P/E ratio
- 17.5
- Price to sales
- 1.73
- Price to book
- 3.23
- Dividend yield
- 0.17%
- Free cash flow yield
- 5.03%
Fundamentals
- Revenue
- $21.64B
- Net income
- $2.15B
- EPS, diluted
- $4.74
- Free cash flow
- $1.89B
- Book value per share
- $25.64
- Diluted shares
- 453M
Trading
- Next earnings
- Feb 3, 2027 (estimated, before the open)
- Previous close
- $81.84
- Open
- $82.43
- Day's range
- $81.84 – $83.09
- Volume
- 2,395,569
- Average volume (20 days)
- 4,250,140
- Index membership
- S&P 500 (since Mar 2023), Nasdaq-100 (since Aug 2023), Russell 1000 (since Mar 2023), Russell 3000 (since Feb 2023)
- Beta (5 years)
- 1.13
- 52-week range
- $58.75 – $89.77
- RSI (14 days)
- 68.1
- Volatility (1 year)
- 35.8%
- Relative volume
- 0.58×
- WACC
- 9.7%
On 1 of our idea list: Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, QQQ, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | GEHC | S&P 500 | Difference | GEHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +20.8% | -3.0% | +23.8 pts | ||
| 3 months | +12.6% | -2.8% | +15.4 pts | ||
| Year to date | +1.4% | +11.5% | −10.1 pts | ||
| 1 year | +12.5% | +13.5% | −1.0 pts | ||
| 3 years | +19.2% | +77.7% | −58.5 pts | +6.0% | +21.1% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases GE HealthCare Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Results
About GE HealthCare Technologies
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital healthcare solutions provider. The company develops and distributes diagnostic imaging systems, patient monitoring devices, ultrasound systems, surgical visualization tools, life support equipment, consumable clinical accessories, and contrast agents. It organizes its business operations into four core segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Alongside physical equipment and pharmaceuticals, the enterprise delivers artificial intelligence tools, cloud platforms, workflow software, and maintenance services. Its client base includes public and private hospitals, integrated health systems, research organizations, academic centers, and government institutions.
Company profile, executives and historyGE HealthCare Technologies stock: common questions
What is GE HealthCare Technologies's stock price?
GEHC closed at $83.02 on Nov 13, 2026, up 1.44% on the day. Over the past 52 weeks it traded between $58.75 and $89.77.
What is GE HealthCare Technologies's market cap?
GE HealthCare Technologies was worth $37.54B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is GEHC's P/E ratio?
GEHC trades at 17.5 times earnings, based on diluted earnings per share of $4.74 over the twelve months to Sep 30, 2026.
How much revenue does GE HealthCare Technologies make?
GE HealthCare Technologies reported revenue of $21.64B for the twelve months to Sep 30, 2026, up 6.9% from a year earlier.
Does GE HealthCare Technologies pay a dividend?
Yes. GE HealthCare Technologies paid $0.14 per share over the last twelve months, a yield of 0.17% at the latest price, and has raised its annual dividend 2 years in a row.
When does GE HealthCare Technologies report earnings next?
GE HealthCare Technologies is expected to report Q4 FY2026 results on Feb 3, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has GEHC stock performed over the past year?
Including dividends, GEHC returned +12.5% over the past year, against +13.5% for the S&P 500.
How many GEHC shares are sold short?
18M shares were sold short at the latest FINRA report, 4.05% of the float, or 4.9 days of average trading volume.
Who are GE HealthCare Technologies's competitors?
Companies most similar to GE HealthCare Technologies by business, industry and size include PHG, BSX, BDX, BAX, MDT.
See a number that looks wrong?